Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Francesca Romana Ponziani, Silvia Pecere, Loris Lopetuso, Franco Scaldaferri, Giovanni Cammarota & Antonio Gasbarrini. (2016) Rifaximin for the treatment of irritable bowel syndrome – a drug safety evaluation. Expert Opinion on Drug Safety 15:7, pages 983-991.
Read now
Read now
Articles from other publishers (3)
Kashif Mohd Siddiqui, Sumeet Attri, Massimo Orlando, Filippo Lelli, Valeria Maida & Dominique Damais-Thabut. (2022) Cost-Effectiveness of Rifaximin-α versus Lactulose for the Treatment of Recurrent Episodes of Overt Hepatic Encephalopathy: A Meta-Analysis. GastroHep 2022, pages 1-13.
Crossref
Crossref
L. B. Lazebnik, E. V. Golovanova, S. A. Alekseenko, A. O. Bueverov, E. Y. Plotnikova, A. I. Dolgushina, L. Y. IlchenkoT. V. Ermolova, L. V. Tarasova, E. D. Lee, Y. V. Tsyganova, V. A. Akhmedov, E. A. Ageeva, V. M. Losev, I. N. Kupriyanova, S. N. Serikova, N. V. Korochanskaya, L. G. Vologzhanina, Y. S. Zimmerman, E. I. Sas, S. V. Zhuravel, S. V. OkovitiyM. F. Osipenko, V. G. Radchenko, G. S. Soldatova, S. I. Sitkin, P. V. Seliverstov, G. V. Shavkuta, E. N. Butova & S. A. Kozhevnikova. (2022) Russian Consensus on “Hyperammonemia in Adults”: The 2021 Version (in English). Experimental and Clinical Gastroenterology:12, pages 154-172.
Crossref
Crossref
L. B. Lazebnik, E. V. Golovanova, S. A. Alekseenko, A. O. Bueverov, E. Yu. Plotnikova, A. I. Dolgushina, L. Yu. IlchenkoT. V. Ermolova, L. V. Tarasova, E. D. Lee, Yu. V. Tsyganova, V. A. Akhmedov, E. A. Ageeva, V. M. Losev, I. N. Kupriyanova, S. N. Serikova, N. V. Korochanskaya, L. G. Vologzhanina, Ya. S. Zimmerman, E. I. Sas, S. V. Zhuravel, S. V. OkovitiyM. F. Osipenko, V. G. Radchenko, G. S. Soldatova, S. I. Sitkin, P. V. Seliverstov, G. V. Shavkuta, E. N. Butova & S. A. Kozhevnikova. (2021) Russian Consensus “Hyperammonemia in Adults” (Version 2021). Experimental and Clinical Gastroenterology:3, pages 97-118.
Crossref
Crossref